ScholarIQanswers from OpenAlex

Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia.

PaperCitations, authors & open-access status

Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. have?

ScholarIQcitation count

Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. has 19 citations in the OpenAlex counts ScholarIQ stores.

When was Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. published?

ScholarIQyear

Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. has 2009 year in the ScholarIQ index.

What is the open-access status of Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia.?

ScholarIQoa status

Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. has closed oa status in the ScholarIQ index.

What is the PMID of Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia.?

ScholarIQpmid

The PMID for Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. is on the source record.

What is the OpenAlex record for Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia.?

ScholarIQopenalex

The OpenAlex for Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial